Assessing HER2 status in breast cancer through next-generation sequencing of circulating tumor cells

Int J Biol Markers. 2024 Jun;39(2):184-185. doi: 10.1177/03936155241246542. Epub 2024 Apr 22.
No abstract available

Publication types

  • Letter

MeSH terms

  • Biomarkers, Tumor / genetics
  • Breast Neoplasms* / blood
  • Breast Neoplasms* / genetics
  • Breast Neoplasms* / pathology
  • Female
  • High-Throughput Nucleotide Sequencing* / methods
  • Humans
  • Neoplastic Cells, Circulating* / metabolism
  • Neoplastic Cells, Circulating* / pathology
  • Receptor, ErbB-2* / genetics
  • Receptor, ErbB-2* / metabolism

Substances

  • Receptor, ErbB-2
  • ERBB2 protein, human
  • Biomarkers, Tumor